Xilio Therapeutics
35 hedge funds and large institutions have $16.2M invested in Xilio Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $16.3M → $16.2M (-$139K)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
35
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$906K | |
| 2 | +$196K | |
| 3 | +$160K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$52.3K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$23.6K |
Top Sellers
| 1 | -$253K | |
| 2 | -$49.4K | |
| 3 | -$37.7K | |
| 4 |
Millennium Management
New York
|
-$37K |
| 5 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$30.8K |
